298 related articles for article (PubMed ID: 7088112)
1. Respiratory syncytial viral infection in infants with congenital heart disease.
MacDonald NE; Hall CB; Suffin SC; Alexson C; Harris PJ; Manning JA
N Engl J Med; 1982 Aug; 307(7):397-400. PubMed ID: 7088112
[TBL] [Abstract][Full Text] [Related]
2. Nosocomial infection: a risk factor for a complicated course in children with respiratory syncytial virus infection--results from a prospective multicenter German surveillance study.
Simon A; Müller A; Khurana K; Engelhart S; Exner M; Schildgen O; Eis-Hübinger AM; Kamin W; Schaible T; Wadas K; Ammann RA; Wilkesmann A;
Int J Hyg Environ Health; 2008 Jul; 211(3-4):241-50. PubMed ID: 17869579
[TBL] [Abstract][Full Text] [Related]
3. Neonatal respiratory syncytial virus infection.
Hall CB; Kopelman AE; Douglas RG; Geiman JM; Meagher MP
N Engl J Med; 1979 Feb; 300(8):393-6. PubMed ID: 759915
[TBL] [Abstract][Full Text] [Related]
4. Pre-existing disease is associated with a significantly higher risk of death in severe respiratory syncytial virus infection.
Thorburn K
Arch Dis Child; 2009 Feb; 94(2):99-103. PubMed ID: 18653625
[TBL] [Abstract][Full Text] [Related]
5. Physiologic risk factors for respiratory viral infections and immunoprophylaxis for respiratory syncytial virus in young children with congenital heart disease.
Cabalka AK
Pediatr Infect Dis J; 2004 Jan; 23(1 Suppl):S41-5. PubMed ID: 14730269
[TBL] [Abstract][Full Text] [Related]
6. Ribavirin aerosol treatment of serious respiratory syncytial virus infection in infants.
Rodriguez WJ; Parrott RH
Infect Dis Clin North Am; 1987 Jun; 1(2):425-39. PubMed ID: 3332796
[TBL] [Abstract][Full Text] [Related]
7. Refractory congestive heart failure after ribavirin in infants with heart disease and respiratory syncytial virus.
Martin JT; Kugler JD; Gumbiner CH; Brown JC; Murphy KR; Colombo JL; McManus BM
Nebr Med J; 1990 Feb; 75(2):23-6. PubMed ID: 2308658
[TBL] [Abstract][Full Text] [Related]
8. Decline in respiratory syncytial virus hospitalizations in a region with high hospitalization rates and prolonged season.
Singleton RJ; Bruden D; Bulkow LR; Varney G; Butler JC
Pediatr Infect Dis J; 2006 Dec; 25(12):1116-22. PubMed ID: 17133156
[TBL] [Abstract][Full Text] [Related]
9. Impact of severe disease caused by respiratory syncytial virus in children living in developed countries.
Simoes EA; Carbonell-Estrany X
Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S13-8; discussion S18-20. PubMed ID: 12671448
[TBL] [Abstract][Full Text] [Related]
10. Control of nosocomial respiratory syncytial viral infections.
Hall CB; Geiman JM; Douglas RG; Meagher MP
Pediatrics; 1978 Nov; 62(5):728-32. PubMed ID: 724317
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of respiratory syncytial virus diseases in hospitalized children in the district of Steyr 1984/85].
Emhofer J; Ploier R; Popow-Kraupp T; Brunhuber W
Padiatr Padol; 1988; 23(1):15-23. PubMed ID: 3260367
[TBL] [Abstract][Full Text] [Related]
12. Respiratory syncytial virus infection in elderly and high-risk adults.
Falsey AR; Hennessey PA; Formica MA; Cox C; Walsh EE
N Engl J Med; 2005 Apr; 352(17):1749-59. PubMed ID: 15858184
[TBL] [Abstract][Full Text] [Related]
13. Nosocomial respiratory syncytial virus infections.
Hall CB; Douglas RG; Geiman JM; Messner MK
N Engl J Med; 1975 Dec; 293(26):1343-6. PubMed ID: 1186836
[TBL] [Abstract][Full Text] [Related]
14. Hospitalized children with respiratory syncytial virus infection and neuromuscular impairment face an increased risk of a complicated course.
Wilkesmann A; Ammann RA; Schildgen O; Eis-Hübinger AM; Müller A; Seidenberg J; Stephan V; Rieger C; Herting E; Wygold T; Hornschuh F; Groothuis JR; Simon A;
Pediatr Infect Dis J; 2007 Jun; 26(6):485-91. PubMed ID: 17529864
[TBL] [Abstract][Full Text] [Related]
15. Rehospitalisations for respiratory disease and respiratory syncytial virus infection in preterm infants of 29-36 weeks gestational age.
Resch B; Pasnocht A; Gusenleitner W; Müller W
J Infect; 2005 Jun; 50(5):397-403. PubMed ID: 15907547
[TBL] [Abstract][Full Text] [Related]
16. [Clinical manifestation and prognosis of respiratory syncytial virus infection in infants].
Matsumoto K
Arerugi; 1992 Dec; 41(12):1679-86. PubMed ID: 1290411
[TBL] [Abstract][Full Text] [Related]
17. Respiratory syncytial virus (RSV) infection in preterm infants and the protective effects of RSV immune globulin (RSVIG). Respiratory Syncytial Virus Immune Globulin Study Group.
Groothuis JR; Simoes EA; Hemming VG
Pediatrics; 1995 Apr; 95(4):463-7. PubMed ID: 7700741
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group.
Groothuis JR; Simoes EA; Levin MJ; Hall CB; Long CE; Rodriguez WJ; Arrobio J; Meissner HC; Fulton DR; Welliver RC
N Engl J Med; 1993 Nov; 329(21):1524-30. PubMed ID: 8413475
[TBL] [Abstract][Full Text] [Related]
19. Infection by the respiratory syncytial virus in infants and young children at high risk.
Bonnet D; Schmaltz AA; Feltes TF
Cardiol Young; 2005 Jun; 15(3):256-65. PubMed ID: 15865827
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of respiratory syncytial virus infection in Italian infants hospitalized for acute lower respiratory tract infections, and association between respiratory syncytial virus infection risk factors and disease severity.
Lanari M; Giovannini M; Giuffré L; Marini A; Rondini G; Rossi GA; Merolla R; Zuccotti GV; Salvioli GP;
Pediatr Pulmonol; 2002 Jun; 33(6):458-65. PubMed ID: 12001280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
